Frequent FGFR3 Mutations in Papillary Non-Invasive Bladder (pTa) Tumors

We recently identified activating mutations of fibroblast growth factor receptor 3 (FGFR3) in bladder carcinoma. In this study we assessed the incidence of FGFR3 mutations in a series of 132 bladder carcinomas: 20 carcinoma in situ (CIS), 50 pTa, 19 pT1, and 43 pT2–4. All 48 mutations identified wer...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Billerey, Claude, Chopin, Dominique, Aubriot-Lorton, Marie-Hélène, Ricol, David, Gil Diez de Medina, Sixtina, Van Rhijn, Bas, Bralet, Marie-Pierre, Lefrere-Belda, Marie-Aude, Lahaye, Jean-Baptiste, Abbou, Claude C., Bonaventure, Jacky, Zafrani, Elie Serge, van der Kwast, Theo, Thiery, Jean Paul, Radvanyi, Francois
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Society for Investigative Pathology 2001
Konular:
Short Communication
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC1891972/
https://ncbi.nlm.nih.gov/pubmed/11395371
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller